Gil-Gomez, A, Rojas, A, Garcia-Lozano, MR, Munoz-Hernandez, R, Gallego-Duran, R, Maya-Miles, D, Montero-Vallejo, R, Gato, S, Gallego, J, Frances, R, Soriano, G, Ampuero, J, Romero-Gomez, M. Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(19)DOI:10.3390/ijms231911840. PMID:36233142. IF:5.600(Q1/3D).

Chaparro, M, Garre, A, Ortiz, AN, Palomares, MTDL, Rodriguez, C, Riestra, S, Vela, M, Benitez, JM, Salgado, EF, Rodriguez, ES, Hernandez, V, Ferreiro-Iglesias, R, Diaz, AP, Barrio, J, Huguet, JM, Sicilia, B, Martin-Arranz, MD, Calvet, X, Ginard, D, Alonso-Abreu, I, Fernandez-Salazar, L, Trastoy, PV, Rivero, M, Vera-Mendoza, I, Vega, P, Navarro, P, Sierra, M, Cabriada, JL, Aguas, M, Vicente, R, Navarro-Llavat, M, Echarri, A, Gomollon, F, del Rio, EG, Pinero, C, Casanova, MJ, Spicakova, K, de Zarate, JO, Cortes, ET, Gutierrez, A, Alonso-Galan, H, Hernandez-Martinez, A, Marrero, JM, Poyatos, RL, Calafat, M, Romero, LM, Robledo, P, Bosch, O, Jimenez, N, Comas, ME, Duque, JM, Coronel, AMF, Sampedro, MJ, Abizanda, ES, Martinez, BH, Pozzati, L, Rosaenz, HF, Suarez, BC, Serrano, PL, Lucendo, AJ, Vicente, MM, Bermejo, F, Palanca, JJR, Menacho, M, Carmona, A, Camargo, R, Alsina, ST, Maroto, N, de la Puerta, JN, Castro, E, Marin-Jimenez, I, Botella, B, Sapina, A, Cruz, N, Forcelledo, JLF, Bouhmidi, A, Castano-Milla, C, Opio, V, Nicolas, I, Kutz, M, Bechiarelli, AA, Gordillo, J, Ber, Y, Dominguez, YT, Duran, MTN, Mondejar, SR, Martinez-Cerezo, FJ, Kolle, L, Sabat, M, Ledezma, C, Iyo, E, Roncero, O, Irisarri, R, Lluis, L, Gomez, IB, Zapata, EM, Alcala, MJ, Pascual, CM, Montealegre, M, Mata, L, Monrobel, A, Camba, AH, Hernandez, L, Tejada, M, Mir, A, Galve, ML, Soler, M, Hervias, D, Gomez-Valero, JA, Acosta, MBD, Rodriguez-Artalejo, F, Garcia-Esquinas, E, Gisbert, JP. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (vol 10, 2885, 2021). Journal of Clinical Medicine. 2022; 11(19)DOI:10.3390/jcm11195816. PMID:36233844. IF:3.900(Q2/4D).

Villanueva, C, Torres, F, Sarin, SK, Shah, HA, Tripathi, D, Brujats, A, Rodrigues, SG, Bhardwaj, A, Azam, Z, Hayes, PC, Jindal, A, Abid, S, Alvarado, E, Bosch, J, Carvedilol IPD MA Grp, Baveno Cooperation EASL Consortium. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. JOURNAL OF HEPATOLOGY. 2022; 77(4)DOI:10.1016/j.jhep.2022.05.021. PMID:35661713. IF:25.700(Q1/1D).

Casado-Llombart, S, Velasco-de Andres, M, Catala, C, Leyton-Pereira, A, Gutierrez-Cozar, R, Suarez, B, Armiger, N, Carreras, E, Esteller, M, Ricart, E, Ordas, I, Gisbert, JP, Chaparro, M, Esteve, M, Marquez, L, Busquets, D, Iglesias, E, Garcia-Planella, E, Martin-Arranz, MD, Lohmann, J, Ayata, CK, Niess, JH, Engel, P, Panes, J, Salas, A, Domenech, E, Lozano, F. Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.966184. PMID:36211446. IF:7.300(Q1/3D).

Chaparro, M, Baston-Rey, I, Salgado, EF, Garcia, JG, Ramos, L, Palomares, MTDL, Arguelles-Arias, F, Flores, EI, Cabello, M, Iturria, SR, Ortiz, AN, Charro, M, Ginard, D, Sadornil, CD, Ochoa, OM, Busquets, D, Iyo, E, Casbas, AG, de la Piscina, PR, Bosca-Watts, MM, Arroyo, M, Garcia, MJ, Hinojosa, E, Gordillo, J, Montiel, PM, Jimenez, BV, Ivorra, CQ, Moron, JMV, Huguet, JM, Gonzalez-Lama, Y, Santos, AIM, Amo, VM, Arranz, MDM, Bermejo, F, Cadilla, JM, de Celix, CR, Salazar, PF, San Roman, AL, Jimenez, N, Garcia-Lopez, S, Figuerola, A, Jimenez, I, Cerezo, FJM, Taxonera, C, Varela, P, de Francisco, R, Monfort, D, Arriero, GM, Hernandez-Camba, A, Alonso, FJG, Van Domselaar, M, Pajares-Villarroya, R, Nunez, A, Moranta, FR, Marin-Jimenez, I, Alonso, VR, Rodriguez, MDM, Camo-Monterde, P, Tercero, IG, Navarro-Llavat, M, Garcia, LA, Cruz, DH, Kloss, S, Passey, A, Novella, C, Vispo, E, Barreiro-de Acosta, M, Gisbert, JP. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab. Journal of Clinical Medicine. 2022; 11(15)DOI:10.3390/jcm11154518. PMID:35956133. IF:3.900(Q2/4D).

Riestra, S, Taxonera, C, Zabana, Y, Carpio, D, Chaparro, M, Barrio, J, Rivero, M, Lopez-Sanroman, A, Esteve, M, de Francisco, R, Bastida, G, Garcia-Lopez, S, Manosa, M, Martin-Arranz, MD, Perez-Calle, JL, Guardiola, J, Munoz, F, Arranz, L, Cabriada, JL, Garcia-Sepulcre, MF, Navarro, M, Montoro-Huguet, MA, Ricart, E, Bermejo, F, Calvet, X, Piqueras, M, Garcia-Planella, E, Marquez, L, Minguez, M, Van Domselar, M, Bujanda, L, Aldeguer, X, Sicilia, B, Iglesias, E, Alcain, G, Perez-Martinez, I, Rolle, V, Castano-Garcia, A, Gisbert, JP, Domenech, E. Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU. Journal of Clinical Medicine. 2022; 11(13)DOI:10.3390/jcm11133915. PMID:35807201. IF:3.900(Q2/4D).

Alvarado-Tapias, E, Maya-Miles, D, Albillos, A, Aller, R, Ampuero, J, Andrade, RJ, Arechederra, M, Aspichueta, P, Banales, JM, Blas-Garcia, A, Caparros, E, Delgado, TC, Carrillo-Vico, A, Claria, J, Cubero, FJ, Diaz-Ruiz, A, Fernandez-Barrena, MG, Fernandez-Iglesias, A, Fernandez-Veledo, S, Frances, R, Gallego-Duran, R, Gracia-Sancho, J, Irimia, M, Lens, S, Martinez-Chantar, ML, Minguez, B, Munoz-Hernandez, R, Nogueiras, R, Ramos-Molina, B, Riveiro-Barciela, M, Rodriguez-Peralvarez, ML, Romero-Gomez, M, Sabio, G, Sancho-Bru, P, Ventura-Cots, M, Vidal, S, Gahete, MD. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH). Gastroenterologia y Hepatologia. 2024; 47(10)DOI:10.1016/j.gastrohep.2024.502207. PMID:38723772. IF:1.900(Q3/7D).

González-Muñoza, C, Gely, C, Gordillo, J, Calafat, M, Bertoletti, F, Cañete, F, Mañosa, M, López-Faba, A, Torres, P, Domènech, E, Garcia-Planella, E. Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease. Gastroenterologia y Hepatologia. 2024; 47(10)DOI:10.1016/j.gastrohep.2024.502193. PMID:38723767. IF:1.900(Q3/7D).